MRP Stock Analysis: Millrose Properties | NYSE

REIT - Residential | NYSE, USA | Market Cap: 3.713m USD | 12M Return: -24.7% | US6011371027 | Charts, Fundamentals & Technical Analysis

Land Banking, Homesite Development, Acquisition Financing, Finished Lots
Total Rating 19
Safety 35
Buy Signal -1.08
REIT - Residential
Industry Rotation: +2.6
Market Cap: 3.71B
Avg Turnover: 76.7M
Risk 3d forecast
Volatility43.1%
VaR 5th Pctl7.38%
VaR vs Median3.96%
Choppyness70.4%
Reward TTM
Sharpe Ratio-0.99
Rel. Str. IBD9.5
Rel. Str. Peer Group12.5
Character TTM
Beta0.746
Beta Downside0.886
Hurst Exponent0.528
Drawdowns 3y
Max DD31.68%
CAGR/Max DD0.27
CAGR/Mean DD0.99

Warnings

High Debt While Negative Cash Flow
Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 1.6 years of data

Jan - -
Feb +2.9% -
Mar -10.8% -
Apr +10.0% -
May -8.1% -
Jun +6.3% -
Jul -2.5% -
Aug +10.9% -
Sep - -
Oct - -
Nov - -
Dec - -

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: MRP Millrose Properties

Millrose Properties, Inc. (NYSE: MRP) is a Miami-based real estate company that provides long-term capital to U.S. residential homebuilders and developers. The company acquires, finances, and develops residential land, delivering finished homesites to homebuilders on a just-in-time basis through capital-efficient structures. Its proprietary technology platform supports acquisition decisions with real-time data analytics, and each transaction is subject to independent due diligence. By offering a permanent capital solution, Millrose enables homebuilder partners to operate under an asset-light model, preserving balance sheet flexibility across varying market conditions.

The company operates within the real estate sector and is classified as a specialized REIT, having completed its IPO in February 2025. Its focus on the residential land and finished lots subsegment addresses what management describes as a constrained supply of entitled, ready-to-build homesites in the U.S. housing market.

Headlines to Watch Out For
  • Mortgage rate declines boost homebuilder demand for finished lots
  • Land acquisition pace accelerates as homebuilders pursue asset-light model
  • Spread compression risk if land costs outpace rent growth
Piotroski VR-10 (Strict) 4.0
Net Income: 476.1m TTM > 0 and > 6% of Revenue
FCF/TA: -0.13 > 0.02 and ΔFCF/TA 8.97 > 1.0
NWC/Revenue: -14.26% < 20% (prev 107k%; Δ -107k% < -1%)
CFO/TA 0.54 > 3% & CFO 5.23b > Net Income 476.1m
Net Debt (2.44b) to EBITDA (673.4m): 3.63 < 3
Current Ratio: 0.44 > 1.5 & < 3
Outstanding Shares: last quarter (166.0m) vs 12m ago -0.00% < -2%
Gross Margin: 88.46% > 18% (prev 118.4%; Δ -29.90% > 0.5%)
Asset Turnover: 8.60% > 50% (prev 0.09%; Δ 8.51% > 0%)
Interest Coverage Ratio: 4.13 > 6 (EBIT TTM 653.1m / Interest Expense TTM 158.2m)
Altman Z'' 2.01
A: -0.01 (Total Current Assets 84.0m - Total Current Liabilities 192.4m) / Total Assets 9.71b
B: -0.00 (Retained Earnings -23.7m / Total Assets 9.71b)
C: 0.07 (EBIT TTM 653.1m / Avg Total Assets 8.84b)
D: 1.52 (Book Value of Equity 5.85b / Total Liabilities 3.86b)
Altman-Z'' = 2.01 = BBB
What is the price of MRP shares?

As of October 15, 2026, the stock is trading at USD 21.22 with a total of 4,937,977 shares traded. Over the past week, the price has changed by -6.19%, over one month by -25.58%, over three months by -22.61% and over the past year by -24.73%.

Current recommended Stop Loss: 19.90 (which is 6.2% or 1.4 ATR below the current price).

Is MRP a buy, sell or hold?

Millrose Properties has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy MRP.

  • StrongBuy: 5
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the MRP price?
Analysts Target Price 36.6 72.5%
Millrose Properties (MRP) - Fundamental Data Overview as of 12 October 2026
Market Cap USD = 3.71b (3.71b USD * 1.0 USD.USD)
P/E Trailing = 7.7909
P/S = 4.8818
P/B = 0.7607
Revenue TTM = 760.5m USD
EBIT TTM = 653.1m USD
EBITDA TTM = 673.4m USD
Long Term Debt = 2.48b USD (from longTermDebt, last quarter)
Short Term Debt = 13.0m USD (from shortTermDebt, last fiscal year)
Debt = 2.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.44b USD (calculated: Debt 2.48b - CCE 34.2m)
Enterprise Value = 6.16b USD (3.71b + Debt 2.48b - CCE 34.2m)
Interest Coverage Ratio = 4.13 (Ebit TTM 653.1m / Interest Expense TTM 158.2m)
EV/FCF = -5.05x (Enterprise Value 6.16b / FCF TTM -1.22b)
FCF Yield = -19.80% (FCF TTM -1.22b / Enterprise Value 6.16b)
 FCF Margin = -160.3% (FCF TTM -1.22b / Revenue TTM 760.5m)
 Net Margin = 62.60% (Net Income TTM 476.1m / Revenue TTM 760.5m)
Gross Margin = 88.46% ((Revenue TTM 760.5m - Cost of Revenue TTM 87.8m) / Revenue TTM)
Gross Margin QoQ = 84.81% (prev 85.56%)
Tobins Q-Ratio = 0.63 (Enterprise Value 6.16b / Total Assets 9.71b)
Interest Expense / Debt = 6.38% (Interest Expense 158.2m / Debt 2.48b)
Taxrate = 3.81% (18.9m / 494.9m)
NOPAT = 628.2m (EBIT 653.1m * (1 - 3.81%))
Current Ratio = 0.44 (Total Current Assets 84.0m / Total Current Liabilities 192.4m)
Debt / Equity = 0.42 (Debt 2.48b / totalStockholderEquity, last quarter 5.85b)
Debt / EBITDA = 3.63 (Net Debt 2.44b / EBITDA 673.4m)
 Debt / FCF = -2.01 (negative FCF - burning cash) (Net Debt 2.44b / FCF TTM -1.22b)
 Total Stockholder Equity = 5.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.39% (Net Income 476.1m / Total Assets 9.71b)
RoE = 8.13% (Net Income TTM 476.1m / Total Stockholder Equity 5.86b)
RoCE = 7.84% (EBIT 653.1m / Capital Employed (Equity 5.86b + L.T.Debt 2.48b))
RoIC = 6.62% (NOPAT 628.2m / Invested Capital 9.49b)
WACC = 7.62% (E(3.71b)/V(6.19b) * Re(8.61%) + D(2.48b)/V(6.19b) * Rd(6.38%) * (1-Tc(0.04)))
Discount Rate = 8.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.57 | Cagr: 9.63%
 [DCF] Fair Price = unknown (Cash Flow -1.22b)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.77 | Chg30d=-2.52% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=3.06 | Chg30d=-1.50% | Revisions=-25% | GrowthEPS=+25.4% | GrowthRev=+35.0%
EPS next Year (2027-12-31): EPS=3.24 | Chg30d=-0.61% | Revisions=-25% | GrowthEPS=+5.8% | GrowthRev=+9.4%
[Analyst] Revisions Ratio: -50% (up=0, down=3)